drugset / Trial / NCT00578448
Belatacept Pharmacokinetic Trial in Renal Transplantation
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the pharmacokinetics and safety of belatacept in de novo renal transplant subjects treated with belatacept-based immunosuppressant medication
Timeline
- Start
- 2008-03
- Primary completion
- 2009-03
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Belatacept | Protein / enzyme biologic | 5 mg/kg | Intravenous |
| Comparator | Belatacept | Protein / enzyme biologic | 10 mg/kg | Intravenous |
Indications
No indication recorded.